Tag Archives: Sentra AM

Research Identifies a Potential New Path to Developing a Treatment for Chronic Pain

Los Angeles, September 8, 2015 – Targeted Medical Pharma to present new chronic pain research that reveals significant nervous system abnormalities among patients suffering from Fibromyalgia, at the 2015 PainWeek national conference in Las Vegas, Nevada. The study looked at 329 Fibromyalgia patients and 58 control patients all of whom wore Holter monitors for a 24 hour period to measure nervous system activity. The results of this study showed that patients with Fibromyalgia experience a significant decrease in both nighttime parasympathetic nervous system (PNS) activity and daytime sympathetic Continue reading →

Targeted Medical Pharma Releases Promising Trial Results for the Treatment of Posttraumatic Stress Disorder

Study Shows Medical Foods Sentra AM and Sentra PM Effective at Reducing Symptoms of PTSD in Veterans Los Angeles, CA, October  13, 2014 — Targeted Medical Pharma, Inc. (OTCQB: TRGM) a drug discovery and development company, today announced the results of a clinical trial studying the amino acid based medical foods, Sentra AM and Sentra PM in Veterans suffering from symptoms associated with Posttraumatic Stress Disorder (PTSD). In this 30 day open label pilot study (n=21), published in the Journal of Central Nervous System Disease, Continue reading →

Targeted Medical Pharma Announces Completion of Sales Agreement with Pacific Medical, Inc

Agreement Provides the Company with the Ability to Rapidly Expand Sales and Education Programs Los Angeles, CA, January 10, 2014 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), reported on the completion of an independent sales agreement with Pacific Medical, Inc., a distributor of durable medical equipment in the United States who specializes in orthopedic, rehabilitation, surgery and sports medicine. The non-exclusive agreement will allow Targeted Medical Pharma to expand medical food sales and education programs to licensed healthcare professionals in Northern California and Northern Nevada Continue reading →

Targeted Medical Pharma to Present at the Demy-Colton 2014 BIOTECH Showcase

Targeted Medical Pharma to Present at the Demy-Colton 2014 BIOTECH Showcase Los Angeles, January 9, 2014 — Targeted Medical Pharma, announced that members of its executive team are scheduled to present the latest information regarding medical foods at the sixth annual Biotech Showcase™ on January 14, 2014 at 4:00 p.m. PST, at the Parc 55 Wyndham Hotel in San Francisco, CA. Management also will conduct one-on-one meetings with investors from January 13-15, 2014. Biotech Showcase is an investor and partnering conference devoted to providing private Continue reading →

Targeted Medical Pharma Reports Initial Results from a Clinical Observation of Medical Foods for Children and Adults with Autistic Spectrum Disorder Symptoms

Addressing the Nutrient Deficiencies Associated with Autism Spectrum Disorders for both Children and Adults Los Angeles, CA, December 23, 2013 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), announced additional preliminary findings from an investigator initiated clinical observation of amino acid based medical foods to address specific nutrient deficiencies in children and young adults with autism spectrum disease (ASD) symptoms. 34 subjects including 29 children and 5 young adults ages seven to twenty-one who were diagnosed with ASD or suffering from related symptoms including explosive behavior, Continue reading →

Targeted Medical Pharma Reports 2013 Second Quarter Financial Results

— Year-Over-Year Revenue Increase of 67% and Gross Profit  Increase of 97% for the first half of 2013– LOS ANGELES—August 14, 2013–Targeted Medical Pharma, Inc. (OTCQB:TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced financial results for its second quarter ended June 30, 2013. The Company continued to post increasing revenue for the second quarter and first half of 2013 compared to the second quarter and first half of 2012. “I am Continue reading →

Five Targeted Medical Pharma Products Listed on U.S. Dept. of Veterans Affairs’ Federal Supply Schedule (FSS)

–Company’s Prescription-Only Medical Foods Now Available for Purchase by Federal Agencies through FSS– Los Angeles, January 7, 2013 — Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced that five of its core prescription-only medical foods are now listed on the U.S. Department of Veterans Affairs’ Federal Supply Schedule (FSS). The Company’s designated products are listed under the FSS category 65IB: Drugs, Pharmaceuticals and Hematology products. The listed products that Continue reading →

Study Finds Loss of Normal Nighttime Parasympathetic Activity in Veterans Suffering from Gulf War Syndrome

Los Angeles, December 12, 2012 — A scientific paper confirming the relationship between autonomic nervous system dysfunction and Gulf War Illness was published online  November 26, 2012  in the Archives of Neurology, according to Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians and pharmacies. The paper, “Cholinergic Autonomic Dysfunction in Veterans with Gulf War Illness,” revealed a blunting or loss of normal nighttime parasympathetic activity in veterans suffering from Gulf War Illness Continue reading →

Targeted Medical Pharma Presents at the California Association of Healthcare Facilities’ Annual Convention

Los Angeles, November 14, 2012 — David Silver, M.D., executive vice president of scientific and medical affairs at Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), discussed the utilization of prescription only medical foods in a skilled nursing setting at this year’s California Association of Health Facilities’ 62nd annual convention, held  in Palm Springs, Calif., on November 12. The presentation, “Safer and More Effective Pharmacologic Alternatives,” focused on the safety and efficacy of prescription medical foods for the long term management of pain, cognitive and Continue reading →

Targeted Medical Pharma Awarded $733,429.00 in Qualifying New Therapeutic Discovery Grants

Grants Cover Theramine® , Sentra PM®, Sentra AM® and GABAdone® Los Angeles, CA, Nov. 1, 2010 /Targeted Medical Pharma Inc. a Specialty Pharma company developing proprietary medical food products distributed through subsidiary Physician Therapeutics announced it has been awarded $733,429.00 in government grants. Under the recently enacted Patient Protection and Affordable Care Act, cash grants were awarded to Qualifying Therapeutic Discovery Projects that showed significant potential in producing new and cost-saving therapies, support job growth and increase U.S. competitiveness. Grants were awarded through a competitive Continue reading →